Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Caladrius (PCT)

The Company's PCT subsidiary is a well-known development and manufacturing partner to the cell therapy industry. PCT works with its clients to overcome the fundamental challenges of cell therapy manufacturing by providing a wide range of innovative services including product and process development, GMP manufacturing, engineering and automation, cell and tissue processing, logistics, storage and distribution, as well as expert consulting and regulatory support. Notably, PCT and Hitachi Chemical Co., Ltd. are engaged in a strategic collaboration to accelerate the creation of a global commercial cell therapy development and manufacturing enterprise with deep engineering expertise. Caladrius recently announced the signing of a definitive agreement by which Hitachi Chemical of America has agreed to acquire Caladrius' 80.1% share of PCT ownership in a transaction that is expected to close in May 2017, subject to, among other closing conditions, approval by Caladrius shareholders.

Search Projects